Trastuzumab biosimilar (Tanvex Biopharma)
曲妥珠单抗生物类似药（Tanvex Biopharma）
Report date: 2022/03/10 10:08:43
Base Information
Drug NameTrastuzumab biosimilar (Tanvex Biopharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[11]
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesTanvex BioPharma Inc
China Registration ClassN/A
Develop Information
Active CompaniesTanvex Biopharma Usa Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A